Picture of Helyx Industries SpA logo

HLX Helyx Industries SpA Share Price

0.000.00%
it flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapMomentum Trap

Momentum

Relative Strength (%)
1m-5.65%
3m-15.68%
6m-9.71%
1yr-12.64%
Volume Change (%)
10d/3m-71.9%
Price vs... (%)
52w High-43.29%
50d MA-11.79%
200d MA-6.97%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)n/a
PEG Ratio (f)n/a
EPS Growth (f)n/a
Dividend Yield (f)n/a
Valuation (ttm)IndustryMarket
Price to Book Value0.95
Price to Tang. Book7.04
Price to Free Cashflown/a
Price to Sales21.88
EV to EBITDA241.81

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-22.71%
Return on Equity-23.06%
Operating Margin-570.81%

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202531st Dec 2026
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2025 / 2026

Blurred out image of Helyx Industries SpA EPS forecast chart

Profile Summary

Helyx Industries SpA, formerly Ulisse Biomed SpA, is an Italy-based company engaged in the healthcare biotech sector. The Company focuses on creating new and transformative diagnostic platforms and products. It creates diagnostic systems that can reach people directly and help increasing the frequency of health monitoring. Its platforms include Sagitta, NanoHybrid and Aptavir. Sagitta is a molecular diagnostics technology platform, capable of detecting and characterizing nucleic acids of viral, bacterial and eukaryotic origin. Sagitta is used to develop assays for Respiratory Viral Panel, Sexually Transmitted Diseases, Infectious Diseases and Oncology. NanoHybrid can be implemented not only to develop diagnostic solutions but also in the field of theranostics: the integration of a diagnostic method with a specific therapeutic intervention aimed at maximizing the effectiveness of the drug, as well as vaccine/immunotherapies monitoring.

Directors

    Last Annual
    December 31st, 2024
    Last Interim
    June 30th, 2025
    Incorporated
    January 1st, 1970
    Public Since
    August 6th, 2021
    No. of Employees
    23
    Sector
    Biotechnology & Medical Research
    Industry
    Healthcare
    Exchange
    it flag iconBorsa Italiana
    Shares in Issue
    25,509,587
    Blurred out image of a map
    Address
    Via Aquileia 17, UDINE, 33100
    Web
    https://helyx.bio/
    Phone
    Contact
    Gabriele Salaris
    Auditors
    AUDIREVI SpA

    HLX Share Price Performance

    Upcoming Events for HLX

    Ulisse Biomed Spa Annual Shareholders Meeting

    Similar to HLX

    Picture of Philogen SpA logo

    Philogen SpA

    it flag iconBorsa Italiana

    FAQ